Homozygous BCMA gene deletion in response to anti-BCMA CAR T cells in a patient with multiple myeloma

被引：197

作者：

Da Via, Matteo C. ^{[1
]}

Dietrich, Oliver ^{[2
]}

Truger, Marietta ^{[3
]}

Arampatzi, Panagiota ^{[4
]}

Duell, Johannes ^{[1
]}

Heidemeier, Anke ^{[5
]}

Zhou, Xiang ^{[1
]}

Danhof, Sophia ^{[1
]}

Kraus, Sabrina ^{[1
]}

Chatterjee, Manik ^{[1
]}

Meggendorfer, Manja ^{[3
]}

Twardziok, Sven ^{[3
]}

Goebeler, Maria-Elisabeth ^{[1
]}

Topp, Max S. ^{[1
]}

Hudecek, Michael ^{[1
]}

Prommersberger, Sabrina ^{[1
]}

Hege, Kristen ^{[6
]}

Kaiser, Shari ^{[6
]}

Fuhr, Viktoria ^{[7
]}

Weinhold, Niels ^{[8
]}

Rosenwald, Andreas ^{[7
]}

Erhard, Florian ^{[9
]}

Haferlach, Claudia ^{[3
]}

Einsele, Hermann ^{[1
]}

Kortuem, K. Martin ^{[1
]}

Saliba, Antoine-Emmanuel ^{[2
]}

Rasche, Leo ^{[1
,10
]}

机构：

[1] Univ Hosp Wurzburg, Dept Internal Med 2, Wurzburg, Germany

[2] Helmholtz Ctr Infect Res, Helmholtz Inst RNA Based Infect Res, Wurzburg, Germany

[3] Munich Leukemia Lab, Munich, Germany

[4] Univ Wurzburg, Core Unit Syst Med, Wurzburg, Germany

[5] Univ Hosp Wurzburg, Dept Radiol, Wurzburg, Germany

[6] Bristol Myers Squibb, San Francisco, CA USA

[7] Univ Wurzburg, Inst Pathol, Wurzburg, Germany

[8] Univ Hosp Heidelberg, Med Klin 5, Heidelberg, Germany

[9] Univ Wurzburg, Inst Virol & Immunobiol, Wurzburg, Germany

[10] Univ Hosp Wurzburg, Mildred Scheel Early Career Ctr, Wurzburg, Germany

来源：

NATURE MEDICINE | 2021年 / 27卷 / 04期

关键词：

D O I：

10.1038/s41591-021-01245-5

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

B cell maturation antigen (BCMA) is a target for various immunotherapies and a biomarker for tumor load in multiple myeloma (MM). We report a case of irreversible BCMA loss in a patient with MM who was enrolled in the KarMMa trial (NCT03361748) and progressed after anti-BCMA CAR T cell therapy. We identified selection of a clone with homozygous deletion of TNFRSF17 (BCMA) as the underlying mechanism of immune escape. Furthermore, we found heterozygous TNFRSF17 loss or monosomy 16 in 37 out of 168 patients with MM, including 28 out of 33 patients with hyperhaploid MM who had not been previously treated with BCMA-targeting therapies, suggesting that heterozygous TNFRSF17 deletion at baseline could theoretically be a risk factor for BCMA loss after immunotherapy.

引用

页码：616 / 619

页数：18

共 28 条

[1] Clinical Activity of REGN1979, a Bispecific Human, Anti-CD20 x Anti-CD3 Antibody, in Patients with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (B-NHL)
Bannerji, Rajat
Allan, John N.
Arnason, Jon E.
Brown, Jennifer R.
Advani, Ranjana H.
Barnes, Jeffrey A.
Ansell, Stephen M.
O'Brien, Susan M.
Chavez, Julio
Duell, Johannes
David, Kevin A.
Martin, Peter
Joyce, Robin M.
Charnas, Robert
Ambati, Srikanth R.
Adriaens, Lieve
Ufkin, Melanie
Zhu, Min
Li, Jingjin
Gasparini, Peter
Ibrahim, Anfal
Jankovic, Vladimir
Fiaschi, Nathalie
Aina, Olulanu
Zhang, Wen
Deering, Raquel P.
Hamon, Sara
Thurston, Gavin
Murphy, Andrew J.
Weinreich, David M.
Yancopoulos, George D.
Lowy, Israel
Sternberg, David
Topp, Max S.
[J]. BLOOD, 2019, 134
[2] T Cells Genetically Modified to Express an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma
Brudno, Jennifer N.
Maric, Irina
Hartman, Steven D.
Rose, Jeremy J.
Wang, Michael
Lam, Norris
Stetler-Stevenson, Maryalice
Salem, Dalia
Yuan, Constance
Pavletic, Steven
Kanakry, Jennifer A.
Ali, Syed Abbas
Mikkilineni, Lekha
Feldman, Steven A.
Stroncek, David F.
Hansen, Brenna G.
Lawrence, Judith
Patel, Rashmika
Hakim, Frances
Gress, Ronald E.
Kochenderfer, James N.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (22) : 2267 - +
[3] Integrating single-cell transcriptomic data across different conditions, technologies, and species
Butler, Andrew
Hoffman, Paul
Smibert, Peter
Papalexi, Efthymia
Satija, Rahul
[J]. NATURE BIOTECHNOLOGY, 2018, 36 (05) : 411 - +
[4] CD44v6-targeted T cells mediate potent antitumor effects against acute myeloid leukemia and multiple myeloma
Casucci, Monica
di Robilant, Benedetta Nicolis
Falcone, Laura
Camisa, Barbara
Norelli, Margherita
Genovese, Pietro
Gentner, Bernhard
Gullotta, Fabiana
Ponzoni, Maurilio
Bernardi, Massimo
Marcatti, Magda
Saudemont, Aurore
Bordignon, Claudio
Savoldo, Barbara
Ciceri, Fabio
Naldini, Luigi
Dotti, Gianpietro
Bonini, Chiara
Bondanza, Attilio
[J]. BLOOD, 2013, 122 (20) : 3461 - 3472
[5] Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications
Chen, Xiaoyu
Schulz-Trieglaff, Ole
Shaw, Richard
Barnes, Bret
Schlesinger, Felix
Kallberg, Morten
Cox, Anthony J.
Kruglyakl, Semyon
Saunders, Christopher T.
[J]. BIOINFORMATICS, 2016, 32 (08) : 1220 - 1222
[6] Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors
Cheng, Jiqiu
Demeulemeester, Jonas
Wedge, David C.
Vollan, Hans Kristian M.
Pitt, Jason J.
Russnes, Hege G.
Pandey, Bina P.
Nilsen, Gro
Nord, Silje
Bignell, Graham R.
White, Kevin P.
Borresen-Dale, Anne-Lise
Campbell, Peter J.
Kristensen, Vessela N.
Stratton, Michael R.
Lingjrde, Ole Christian
Moreau, Yves
Van Loo, Peter
[J]. NATURE COMMUNICATIONS, 2017, 8
[7] B cell maturation antigen-specific CAR T cells are clinically active in multiple myeloma
Cohen, Adam D.
Garfall, Alfred L.
Stadtmauer, Edward A.
Melenhorst, J. Joseph
Lacey, Simon F.
Lancaster, Eric
Vogl, Dan T.
Weiss, Brendan M.
Dengel, Karen
Nelson, Annemarie
Plesa, Gabriela
Chen, Fang
Davis, Megan M.
Hwang, Wei-Ting
Young, Regina M.
Brogdon, Jennifer L.
Isaacs, Randi
Pruteanu-Malinici, Iulian
Siegel, Don L.
Levine, Bruce L.
June, Carl H.
Milone, Michael C.
[J]. JOURNAL OF CLINICAL INVESTIGATION, 2019, 129 (06) : 2210 - 2221
[8] Defining an Optimal Dual-Targeted CAR T-cell Therapy Approach Simultaneously Targeting BCMA and GPRC5D to Prevent BCMA Escape-Driven Relapse in Multiple Myeloma
de Larrea, Carlos Fernandez
Staehr, Mette
Lopez, Andrea, V
Ng, Khong Y.
Chen, Yunxin
Godfrey, William D.
Purdon, Terence J.
Ponomarev, Vladimir
Wendel, Hans-Guido
Brentjens, Renier J.
Smith, Eric L.
[J]. BLOOD CANCER DISCOVERY, 2020, 1 (02): : 146 - 154
[9] Estimating pseudocounts and fold changes for digital expression measurements
Erhard, Florian
[J]. BIOINFORMATICS, 2018, 34 (23) : 4054 - 4063
[10] Garfall AL, 2019, NATURE, V575, P450, DOI 10.1038/d41586-019-03495-3

← 1 2 3 →